Response to infliximab is related to disease duration in paediatric Crohn's disease.

Autor: Lionetti, P.1 (AUTHOR), Bronzini, F.1 (AUTHOR), Salvestrini, C.1 (AUTHOR), Bascietto, C.2 (AUTHOR), Canani, R. Berni3 (AUTHOR), Dé Angelis, G. L.4 (AUTHOR), Guariso, G.5 (AUTHOR), Martelossi, S.6 (AUTHOR), Papadatou, B.7 (AUTHOR), Barabino, A.8 (AUTHOR)
Zdroj: Alimentary Pharmacology & Therapeutics. Aug2003, Vol. 18 Issue 4, p425-431. 7p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje